High doses of PUFAs didn't differentially affect lean tissue accumulation in middle-aged individuals with overweight, as in the elderly and young lean populations.
The U.S. Food and Drug Administration's website showed on Monday one dose of Novo Nordisk's weight-loss drug Wegovy as available after being in short supply, while three.